These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24755633)

  • 1. Stimulant dependence and stimulant-associated psychosis: clinical characteristics and age of onset in a native American community sample.
    Gilder DA; Gizer IR; Lau P; Ehlers CL
    J Addict Med; 2014; 8(4):241-8. PubMed ID: 24755633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Item response theory analyses of DSM-IV and DSM-5 stimulant use disorder criteria in an American Indian community sample.
    Gilder DA; Gizer IR; Lau P; Ehlers CL
    Drug Alcohol Depend; 2014 Feb; 135():29-36. PubMed ID: 24200103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbid psychiatric diagnoses and their association with cocaine-induced psychosis in cocaine-dependent subjects.
    Tang YL; Kranzler HR; Gelernter J; Farrer LA; Cubells JF
    Am J Addict; 2007; 16(5):343-51. PubMed ID: 17882604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in associations between cannabis and stimulant disorders in first admission psychosis.
    Sara G; Burgess P; Malhi GS; Whiteford H; Hall W
    Schizophr Res; 2013 Jul; 147(2-3):216-22. PubMed ID: 23684162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of nonmedical use of stimulants and methamphetamine use in a national sample.
    Chen LY; Strain EC; Alexandre PK; Alexander GC; Mojtabai R; Martins SS
    Addict Behav; 2014 May; 39(5):829-36. PubMed ID: 24583271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extra-medical stimulant dependence among recent initiates.
    O'Brien MS; Anthony JC
    Drug Alcohol Depend; 2009 Sep; 104(1-2):147-55. PubMed ID: 19515516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key differences in treatment-seeking stimulant users attending a specialised treatment service: a means of early intervention?
    Arunogiri S; Petrie M; Sharkey M; Lubman DI
    Australas Psychiatry; 2017 Jun; 25(3):246-249. PubMed ID: 28068828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.
    Grant BF; Saha TD; Ruan WJ; Goldstein RB; Chou SP; Jung J; Zhang H; Smith SM; Pickering RP; Huang B; Hasin DS
    JAMA Psychiatry; 2016 Jan; 73(1):39-47. PubMed ID: 26580136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulant use disorders: characteristics and comorbidity in an Australian population sample.
    Sara G; Burgess P; Harris M; Malhi GS; Whiteford H; Hall W
    Aust N Z J Psychiatry; 2012 Dec; 46(12):1173-81. PubMed ID: 22990432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific impact of stimulant, alcohol and cannabis use disorders on first-episode psychosis: 2-year functional and symptomatic outcomes.
    Ouellet-Plamondon C; Abdel-Baki A; Salvat É; Potvin S
    Psychol Med; 2017 Oct; 47(14):2461-2471. PubMed ID: 28424105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine dependence and psychiatric and substance use comorbidities in a sample of American Indian male veterans.
    Dickerson DL; O'Malley SS; Canive J; Thuras P; Westermeyer J
    Drug Alcohol Depend; 2009 Jan; 99(1-3):169-75. PubMed ID: 18845405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine dependence and psychiatric and substance use disorder comorbidities among American Indians/Alaska Natives: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Moghaddam JF; Dickerson DL; Yoon G; Westermeyer J
    Drug Alcohol Depend; 2014 Nov; 144():127-33. PubMed ID: 25240520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate of progression from first use to dependence on cocaine or opioids: a cross-substance examination of associated demographic, psychiatric, and childhood risk factors.
    Sartor CE; Kranzler HR; Gelernter J
    Addict Behav; 2014 Feb; 39(2):473-9. PubMed ID: 24238782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between gender and psychotic symptoms in cocaine-dependent and methamphetamine-dependent participants.
    Mahoney JJ; Hawkins RY; De La Garza R; Kalechstein AD; Newton TF
    Gend Med; 2010 Oct; 7(5):414-21. PubMed ID: 21056868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anhedonia associated with stimulant use and dependence in a population-based sample of American adults.
    Leventhal AM; Brightman M; Ameringer KJ; Greenberg J; Mickens L; Ray LA; Sun P; Sussman S
    Exp Clin Psychopharmacol; 2010 Dec; 18(6):562-9. PubMed ID: 21186931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographic and clinical characteristics of current comorbid psychiatric disorders in a randomized clinical trial for adults with stimulant use disorders.
    Warden D; Sanchez K; Greer T; Carmody T; Walker R; Dela Cruz A; Toups M; Rethorst C; Trivedi MH
    Psychiatry Res; 2016 Dec; 246():136-141. PubMed ID: 27693866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocaine-induced psychosis and impulsivity in cocaine-dependent patients.
    Roncero C; Daigre C; Grau-López L; Rodríguez-Cintas L; Barral C; Pérez-Pazos J; Gonzalvo B; Corominas M; Casas M
    J Addict Dis; 2013; 32(3):263-73. PubMed ID: 24074192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does accumulating exposure to illicit drugs bring forward the age at onset in schizophrenia?
    Power BD; Dragovic M; Jablensky A; Stefanis NC
    Aust N Z J Psychiatry; 2013 Jan; 47(1):51-8. PubMed ID: 23042939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns and Characteristics of Methamphetamine Use Among Adults - United States, 2015-2018.
    Jones CM; Compton WM; Mustaquim D
    MMWR Morb Mortal Wkly Rep; 2020 Mar; 69(12):317-323. PubMed ID: 32214077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased prevalence of self-reported psychotic illness predicted by crystal methamphetamine use: Evidence from a high-risk population.
    Lappin JM; Roxburgh A; Kaye S; Chalmers J; Sara G; Dobbins T; Burns L; Farrell M
    Int J Drug Policy; 2016 Dec; 38():16-20. PubMed ID: 27842249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.